Tumor angiogenesis is an inevitable process of tumor growth and metastasis. If angiogenesis is blocked or lacked, tumor won’t grow or metastasize. Special drugs can be used to eliminate and inhibit neovascularization, which could stop tumor growth, metastasis and spread. Anti-angiogenesis therapy has been approved by American FDA and other 28 countries from the European Community.
At present, there are two effective anti-angiogenesis drugs in the world, which are AVASTIN and ENDOSTAR, etc. Enrostatin, which is similar to Endostar, is a multi-targeted anti-angiogenesis drug developed by China and has good effect on non-small-cell lung cancer and other cancers.
